Proteomics Intl Labs Ltd has released a press release.
Share Purchase Plan Offer Booklet
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- $4.5m placement to launch Promarker diagnostics
- Trading Halt
- Pause in Trading
- Australian patent granted for OxiDx oxidative stress test
- Response to ASX Aware Query
Later from Proteomics International Laboratories
- Chinese patent granted for OxiDx technology
- PromarkerEndo latest results presented at world congress
- $12 million capital raise completed with oversubscribed SPP
- A landmark in non-invasive Esophageal Cancer diagnosis
- Supplementary Prospectus
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories